Hepatitis B virus (HBV) is endemic in many parts of the world and is a significant cause of
chronic liver damage and hepatocellular carcinoma. HBV therapeutics vary according to the …

Written for practitioners in the field, this critically acclaimed bestseller provides authoritative
information focused on the investigation of drug-related deaths and practical approaches to …

Current approaches to prevention of blood-borne infections in injection drug users include
referral to drug abuse treatment, access to sterile syringes, bleach disinfection of injection …

The objective of this study was to compare sociodemographic, drug, and sexual risk
characteristics between hepatitis C virus (HCV) baseline positive and negative young (13-24 …

Young injection drug users (IDUs) in San Francisco may be at high risk for hepatitis C virus
(HCV) infection despite access to several needle exchange venues. The authors conducted …

Background: Injection drug users (IDUs) are at high-risk for hepatitis B virus (HBV) and HIV.
Due to concerns about non-adherence to multi-dose vaccine regimens however, IDUs are …

Background High quality care is crucial in ensuring that women and newborns receive
interventions that may prevent and treat birth-related complications. As facility deliveries …

Introduction: We examined correlates of HBV infection and vaccination and the missed
vaccination opportunities among young injection drug users (IDUs) and non-injection drug …

Injection drug users (IDUs) are at high risk for hepatitis B virus (HBV); however, they often do
not receive preventive vaccination.'IDUs who use mobile health care services linked to a …

OBJECTIVE: This article reviews the literature on the impact of HIV/AIDS, hepatitis B and C
viruses (HBV, HCV), and tuberculosis on minority drug injectors in the United States …